Sunspeaks Ventures, Inc. – Our Latest Momentum Play
UPDATE: We no longer cover SNPK and this update is to close out our coverage with a summary of results. We alerted our subscribers to SNPK on the morning of March 8, 2012 by email, and later posted an alert for non-subscribers on March 12. Subscribers could have purchased SNPK the morning of March 8 in the mid 30s cent range and sold 4 to 6 weeks later in the $1.60 to $2.25 range. Theoretically the maximum profit on this stock based on our alert was 757%, but in reality alert investors should have made profits in the 360% to 550% range.
Original Post to this Site:
Our latest momentum play is Sunpeaks Ventures, Inc. (OTCQB:SNPK).
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”), is a distributor of specialty drugs and over-the-counter branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin, a popular blood thinner that has a long list of known adverse drug and food interactions.
Sunspeaks has reported almost no revenues through December 31, 2011 and negative equity as of that date. Although SNPK has been quoted on the OTCQB since last October, it did not begin trading until last Thursday, March 8th.
As with our other momentum alerts, we bring this company to your attention because of the increase in investor awareness and we believe things could get interesting very soon.
In particular, SNPK is now being promoted by one of the most successful stock promoters in business today. Just the fact that this particular investor awareness firm is working with Sunspeaks has drawn additional attention to the company. And this company says it will be promoting SNPK for about a month, in contrast to many awareness programs that last only a day or week. So we wanted to make sure our readers were aware of this one.
SNPK is definitely not for long term value investors. This one is for risk seeking investors prepared to lose their entire investment in exchange for the chance to make a large, exciting profit within a short period of time.
As noted above, SNPK just began trading last Thursday. It traded in the $0.28 – $0.62 range and closed at $0.60 on Friday.
As we said, SNPK is only for those looking for a highly speculative play. All the attention paid to SNPK will likely drive a lot of volume, but this does not mean prices will go up. No one should bet the rent money or college tuition fund on this one.
Investors interested in SNPK should be prepared to get in quickly when they feel the time is right, watch the stock closely and take their profits (if any) at a level they choose. On the buy side, we recommend that investors limit their bid price so they get in at a reasonable price. If the stock turns out to have a dramatic price rise and they miss out because of a low bid, there’s always next time. In our opinion this is much better than getting stuck buying near the peak price.
Investors in SNPK should be prepared to lose their entire investment.
Always remember to do your own due diligence, checking up company filings and consulting with an investment professional. Additionally, remember our disclaimer.
NOTICE: This article was based on research of stock market information and other sources of information, found both online and in print media. Neither StockTips.com nor any of its owners, contributors, officers, directors, consultants, or employees take responsibility for the accuracy of the information contained in this article or the accuracy of the information on which this article was based. StockTips.com was not compensated by any of the companies mentioned in this article for the preparation of this material, nor were the materials approved by the companies which were mentioned.